Septerna, Inc. (SEPN)
NASDAQ · Manufacturing · Pharmaceutical preparations
$37.77−$0.3600 (−0.94%) on the dayAs of the close; data may be delayed.
SEPN price, last 12 months
Key stats
- Previous close
- $38.13
- Open
- $38.34
- Day range
- $37.35 – $38.34
- 52-week range
- $16.22 – $51.10
- Volume
- 259.7K
- Avg volume (20 days)
- 330.6K
- Market cap
- $1.8B
Performance
1W−2.4%
1M−6.2%
3M+1.2%
6M+52.7%
YTD+35.5%
1Y+123.4%
vs S&P 500, 1Y+106.6 pts
Technicals and fundamentals
About Septerna, Inc.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.8B